Streptococcus anginosus Group of Bacteria as an Underappreciated Cause of Pneumonia - Scorecard - MDSpire

Streptococcus anginosus Group of Bacteria as an Underappreciated Cause of Pneumonia

  • By

  • Rebecca E Sell

  • Derek Juang

  • Paul Stark

  • Kathleen Jacobs

  • Alexandrea O Cronin

  • Sharon L Reed

  • Joshua Fierer

  • September 9, 2025

  • 0 min

Share

Clinical Scorecard: The Role of Streptococcus anginosus Group in Community-Acquired Pneumonia: An Overlooked Pathogen

At a Glance

CategoryDetail
ConditionCommunity-acquired pneumonia complicated by empyema caused by Streptococcus anginosus group (SAG)
Key MechanismsSAG bacteria, part of normal oral flora, cause subacute pneumonia leading to empyema via contiguous spread; often misdiagnosed as atelectasis on imaging
Target PopulationAdult patients, mostly middle-aged men with comorbidities predisposing to aspiration or impaired secretion clearance
Care SettingHospital settings including tertiary, quaternary, and VA medical centers

Key Highlights

  • SAG organisms, especially Streptococcus intermedius, are an underrecognized cause of community-acquired pneumonia leading to empyema.
  • Empyema caused by SAG can occur in pure culture or polymicrobial infections, with polymicrobial cases often linked to mediastinitis and malignancy.
  • Contrast-enhanced CT with Hounsfield unit measurement helps differentiate pneumonia adjacent to empyema from atelectasis.

Guideline-Based Recommendations

Diagnosis

  • Consider SAG as a causative pathogen in empyema and pneumonia, especially when pleural fluid cultures grow SAG in pure culture.
  • Use contrast-enhanced CT scans with Hounsfield unit measurements to identify pneumonia adjacent to empyema and distinguish it from atelectasis.
  • Recognize that sputum cultures may be limited due to contamination with oral flora and that SAG may be overlooked as normal flora.

Management

  • Treat SAG empyema as a complication of pneumonia, with appropriate antimicrobial therapy targeting SAG species.
  • Address underlying risk factors such as aspiration risk, substance use (alcohol, sedatives, narcotics), and comorbidities.
  • Consider surgical intervention if indicated for empyema drainage.

Monitoring & Follow-up

  • Monitor clinical response to therapy and resolution of empyema via imaging and clinical parameters.
  • Repeat imaging may be necessary to assess resolution of pneumonia and empyema.

Risks

  • Delayed or missed diagnosis due to misinterpretation of pneumonia as atelectasis.
  • Polymicrobial infections associated with mediastinitis and malignancy increase complexity and risk.
  • Substance use and comorbidities increase susceptibility and complicate management.

Patient & Prescribing Data

Adults with SAG empyema, often with comorbidities and substance use history

Empiric and targeted antimicrobial therapy should cover SAG species; recognition of SAG as a pathogen may improve treatment specificity and outcomes

Clinical Best Practices

  • Include SAG bacteria in differential diagnosis of community-acquired pneumonia complicated by empyema.
  • Utilize contrast-enhanced CT scans with Hounsfield unit measurements to accurately diagnose pneumonia adjacent to empyema.
  • Obtain pleural fluid cultures and interpret SAG growth as potentially pathogenic rather than commensal.
  • Assess and manage patient risk factors such as aspiration risk and substance use.
  • Recognize polymicrobial SAG infections in patients with mediastinitis or malignancy for tailored management.

References

Original Source(s)

Related Content